Results

Total Results: 13 records

Showing results for "lmwh prophylaxis".

  1. psnet.ahrq.gov/web-mm/around-block
    July 01, 2018 - surgeon, recognizing the risk of deep vein thrombosis (DVT), prescribed enoxaparin (Lovenox) for DVT prophylaxis … The Commentary In this case, a patient received low molecular-weight heparin (LMWH) around the time … For instance, should this patient have received pharmacologic DVT prophylaxis at all? … Although intermittent pneumatic compression devices are an alternative to pharmacologic prophylaxis, … Low molecular weight heparin and neuraxial anesthesia.
  2. psnet.ahrq.gov/web-mm/ounce-prevention
    April 10, 2024 - Low-molecular-weight heparin (LMWH) is recommended as pharmacologic prophylaxis. … In some patients, however, the use of LMWH may be precluded, usually because of the risk of bleeding. … graduated compression stockings, pneumatic compression boots, unfractionated heparin, LMWH, or warfarin … General surgery UFH 5,000 units q 8h, 1 st dose 2h preoperatively, continued for 7 days or LMWH once … UFH = unfractionated heparin, LMWH = low-molecular-weight heparin, GCS = graduated compression stockings
  3. psnet.ahrq.gov/sites/default/files/2023-06/hurried_huddle_0.pdf
    January 01, 2023 - molecular weight heparin (LMWH) … molecular weight heparin (LMWH) 40 mg once daily or unfractionated heparin (UFH) twice daily in all … Neuraxial anesthesia in obstetric patients receiving thromboprophylaxis with unfractionated or low-molecular-weight … Epidural hematoma following low molecular weight heparin prophylaxis and spinal anesthesia for cesarean … Comparison of continuation of low-molecular-weight heparin versus switching to unfractionated heparin
  4. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.113_slideshow.ppt
    January 01, 2006 - Prophylaxis Candidacy for VTE prophylaxis based on risk profile of both the individual and the clinical … inpatients with hospital-acquired DVT had received prophylaxis Goldhaber SZ, et al. … in Surgical Settings UFH = unfractionated heparin LMWH = low molecular weight heparin Indication Prevention … Strategy General Surgery UFH 5,000 units q 8h, 1st dose 2h preoperatively, continued for 7 days or LMWH … Use LMWH in high-risk prophylactic doses Such as enoxaparin 30 mg q 12 hours Geerts WH, et al.
  5. psnet.ahrq.gov/web-mm/hurried-team-huddle-and-poor-communication-unsafe-practice-during-anesthesia-emergency
    August 30, 2023 - molecular weight heparin (LMWH). … molecular weight heparin (LMWH) 40 mg once daily or unfractionated heparin (UFH) twice daily in all … Neuraxial anesthesia in obstetric patients receiving thromboprophylaxis with unfractionated or low-molecular-weight … Epidural hematoma following low molecular weight heparin prophylaxis and spinal anesthesia for cesarean … Comparison of continuation of low-molecular-weight heparin versus switching to unfractionated heparin
  6. psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.398_slideshow.ppt
    February 01, 2017 - EHR Boxes (4) In reviewing the death, the case review committee discovered the patient had been given low-molecular-weightheparin (LMWH) for venous thromboembolism (VTE) prophylaxis during the first admission. … The provider did not realize she had prescribed the LMWH and stated she certainly didn't intend to prescribe … EHR), and that she was used to ordering it as nearly all patients she admitted met criteria for VTE prophylaxis … orders. * Case: Ticking All the EHR Boxes (5) The case review committee determined that ordering the LMWH
  7. psnet.ahrq.gov/issue/prescribing-errors-low-molecular-weight-heparins
    July 26, 2017 - Anticoagulants , such as low-molecular-weight heparin (LMWH), are known to be high-risk for adverse … errors – primarily lack of dosage adjustment for body weight and/or renal function – among one-third of LMWH … November 9, 2022 Modes of failure in venous thromboembolism prophylaxis.
  8. psnet.ahrq.gov/web-mm/central-line-clot
    October 08, 2014 - Dosing of low molecular weight heparin (LMWH) in children is similar to the adult population.( 17,18 … ) However, there have been no clinical trials evaluating LMWH for DVT prophylaxis in this population. … Low molecular weight heparin in children. Eur J Pediatr. 2002:161;71-7.[ go to PubMed ] 18. … Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. … prophylaxis No data on efficacy in children Heparin-bonded catheters One RCT in
  9. psnet.ahrq.gov/web-mm/hidden-heparins-hit-happens
    March 27, 2024 - Unfractionated heparin (UFH) is associated with HIT more frequently than low-molecular-weight heparin … (LMWH). … Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis … Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. … Description Indication Dosing Comment Argatroban Synthetic direct thrombin inhibitor Prophylaxis
  10. psnet.ahrq.gov/web-mm/hazards-distraction-ticking-all-ehr-boxes
    April 01, 2013 - In reviewing the death, the case review committee discovered the patient had been given low-molecular-weightheparin (LMWH) for venous thromboembolism (VTE) prophylaxis during the first admission. … step back at this point and say that any competent care provider should have realized that prescribing low-molecular-weightheparin for a patient with a subdural hematoma is contraindicated. … Even if the order set in this case contained a warning beside the order for low-molecular-weight heparin
  11. psnet.ahrq.gov/web-mm/anticoagulation-held-too-long
    April 01, 2008 - anticoagulation ("bridging" therapy) with intravenous unfractionated heparin (UFH) or subcutaneous low-molecular-weightheparin (LMWH) increases the risk of bleeding. … Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing … Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial … Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment
  12. psnet.ahrq.gov/sites/default/files/2021-02/final_feb_2021_spotlight_delay_in_appropriate_dx.pdf
    January 01, 2021 - occurs in up to 7% of patients, with 1.3% developing PE • Despite this increased risk, routine VTE prophylaxis … ., thrombectomy) may be considered • Submassive PE is treated with anticoagulation, either a DOAC, lowmolecular weight heparin (LMWH), or unfractionated heparin (UFH) … Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH
  13. psnet.ahrq.gov/web-mm/delay-appropriate-diagnosis-and-treatment-leading-death-pulmonary-embolism
    November 25, 2020 - occurs in up to 7% of patients, with 1.3% developing PE. 3-5 Despite this increased risk, routine VTE prophylaxis … thrombectomy) may be considered. 35 Submassive PE is treated with anticoagulation, either a DOAC, lowmolecular weight heparin (LMWH), or unfractionated heparin (UFH). … Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: